SCHEMBL13348267

SCHEMBL13348267

CCCCN1CCCc2cccc(OCc3ccc(CCC)c(F)c3)c21

nearest known ligand 0.48

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
RXRA P19793 7/20 0.48
RXRB P28702 6/20 0.48
RXRG P48443 5/20 0.48
HRH3 Q9Y5N1 1/20 0.45
FFAR1 O14842 1/20 0.39
HTR6 P50406 1/20 0.36
HTR2A P28223 2/20 0.35
MRGPRX4 Q96LA9 1/20 0.34
PTGER4 P35408 1/20 0.34
PTGER2 P43116 1/20 0.34
ACHE P22303 2/20 0.33
MAOB P27338 2/20 0.33
PPARG P37231 2/20 0.33
POLB P06746 1/20 0.33
RECQL P46063 1/20 0.33
MEN1 O00255 1/20 0.33
ALDH1A1 P00352 1/20 0.33
KMT2A Q03164 1/20 0.33
PPARA Q07869 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13348052 0.94 RXRA (0.49) RXRARXRBRXRGHRH3FFAR1
SCHEMBL13348047 0.91 RXRA (0.50) RXRARXRBRXRGHRH3FFAR1
SCHEMBL13348154 0.91 RXRA (0.46) RXRARXRBRXRGHRH3FFAR1
SCHEMBL13312162 0.90 RXRA (0.63) RXRARXRBRXRGHRH3FFAR1
SCHEMBL13348161 0.88 RXRA (0.51) RXRARXRBRXRGHRH3FFAR1
SCHEMBL13312585 0.88 RXRA (0.51) RXRARXRBRXRGHRH3FFAR1
SCHEMBL13348293 0.88 RXRA (0.47) RXRARXRBRXRGHRH3FFAR1
SCHEMBL13348265 0.85 RXRA (0.47) RXRARXRBRXRGHRH3FFAR1
SCHEMBL13312165 0.84 RXRA (0.65) RXRARXRBRXRGHRH3FFAR1
SCHEMBL13348294 0.83 RXRA (0.48) RXRARXRBRXRGHRH3HTR6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100152165-A1 CARBOXYLIC ACID DERIVATIVES ASTELLAS PHARMA INC. (JP) 2010-06-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100152165-A1 CARBOXYLIC ACID DERIVATIVES GPR119, GPR65, HCAR1 RXRA 475/4885RXRB 465/4885RXRG 541/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.